Page 83 - 《中国药房》2023年17期
P. 83

基于代谢组学探讨快松饮防治便秘的作用机制
                                                                                 Δ


                                                           3
                                                                    3
                                                                            1 #
                                                   1
                          2
                                           1
                 1*
          于小聪 ,刘沈林 ,王泽琨 ,李丹婷 ,赵毅萌 ,陈 辰 ,陈亚军 ,束雅春 (1.南京中医药大学附属医院药学
                                   1
          部,南京 210029;2.南京中医药大学附属医院脾胃病科,南京 210029;3.南京市妇幼保健院检验科,南京
          210004)
          中图分类号  R965;R285      文献标志码  A      文章编号  1001-0408(2023)17-2121-07
          DOI  10.6039/j.issn.1001-0408.2023.17.13
          摘  要  目的  探讨快松饮防治便秘的作用机制。方法  采用复方地芬诺酯片建立小鼠和大鼠的慢传输型便秘模型。取 2 批小
          鼠,分别分为空白组,模型组,阳性对照组(麻仁软胶囊,0.64 g/kg),快松饮低、中、高剂量组(3.2、6.4、12.8 g/kg),每组10只;通过小
          鼠肠推进实验、小鼠排便实验考察快松饮防治便秘的效果。取大鼠分为空白组,模型组,阳性对照组(麻仁软胶囊,0.36 g/kg),快
          松饮低、高剂量组(2.4、4.8 g/kg),每组7或8只;每天给药1次,连续给药1周后,利用超高效液相色谱-飞行时间质谱技术对大鼠血
          清、尿液进行代谢组学分析。结果  与模型组比较,快松饮高剂量组小鼠墨汁推进率显著升高、5 h 内排便数量显著增加(P<
          0.05),快松饮中、高剂量组小鼠的首次排便时间显著缩短、5 h内排便质量显著增加(P<0.05或P<0.01)。血清代谢组学筛选得到
          16个差异代谢物(如脯氨酸、丙酰基肉碱、硬脂酰溶血性磷脂酰胆碱等)和6条代谢通路(如鞘磷脂代谢、精氨酸和脯氨酸代谢、鞘
          糖脂生物合成-乳糖和新内酯系列等);尿液代谢组学筛选得到20个差异代谢物(如前列腺素A2、L-缬氨酸、硬脂酰磷脂酰胆碱、鞘
          磷脂等)和8条代谢通路(如缬氨酸、亮氨酸和异亮氨酸生物合成,鞘磷脂代谢,丙酮酸代谢等)。结论  快松饮可通过回调硬脂酰
          溶血性磷脂酰胆碱、硬脂酰磷脂酰胆碱、前列腺素A2、L-缬氨酸、脯氨酸等差异代谢物以及调节多种氨基酸代谢途径、鞘磷脂代谢
          通路等来发挥改善便秘的作用。
          关键词  快松饮;便秘;药效学;代谢组学;慢传输型便秘


          Investigation  on  the  mechanism  of  Kuaisong  yin  in  the  prevention  and  treatment  of  constipation  based  on
          metabonomics
                                                                            1
                      1
          YU Xiaocong ,LIU Shenlin ,WANG Zekun ,LI Danting ,ZHAO Yimeng ,CHEN Chen ,CHEN Yajun ,SHU
                                                             1
                                  2
                                                 1
                                                                                         3
                                                                                                       3
                1
          Yachun(1.  Dept.  of  Pharmacy,  the Affiliated  Hospital  of  Nanjing  University  of TCM,  Nanjing  210029,China;
          2.  Dept.  of  Spleen  and  Stomach  Diseases,the  Affiliated  Hospital  of  Nanjing  University  of  TCM,  Nanjing
          210029,China;3.  Dept.  of  Clinical  Laboratory,  Nanjing  Maternal  and  Child  Health  Hospital,  Nanjing  210004,
          China)
          ABSTRACT   OBJECTIVE  To  explore  the  mechanism  of  Kuaisong  yin  in  the  prevention  and  treatment  of  constipation.
          METHODS  Slow  transit  constipation (STC)  model  was  established  with  Compound  difenoxylate  tablet  in  mice  and  rats.  Two
          batches  of  mice  were  divided  into  blank  group,  model  group,  positive  control  group (Maren  soft  capsule,  0.64  g/kg),  Kuaisong
          yin low-dose, medium-dose and high-dose groups (3.2, 6.4, 12.8 g/kg), with 10 mice in each group. The effect of Kuaisong yin
          on  constipation  in  mice  was  evaluated  by  intestinal  propulsion  experiment  and  defecation  experiment.  Rats  were  divided  into  blank
          group,  model  group,  positive  control  group (Maren  soft  capsule,0.36  g/kg),  Kuaisong  yin  low-dose  and  high-dose  groups (2.4,
          4.8 g/kg), with 7 or 8 rats in each group. They were given relevant medicine once a day for 1 week. The metabonomics of serum
          and urine of rats were analyzed by UPLC-Q-TOF-MS/MS technology. RESULTS Compared with model group, the ink propulsion
          rate  and  5  h  defecation  volume  of  mice  in  Kuaisong  yin  high-dose  group  were  significantly  increased (P<0.05);  the  first
          defecation  time  of  mice  in  Kuaisong  yin  medium-dose  and  high-dose  groups  was  significantly  shortened,  and  the  quality  of
          defecation  was  significantly  reduced  within  5  h (P<0.05  or  P<0.01).  Serum  metabonomics  screened  16  compounds (such  as
          proline,  propionylcarnitine,  hemolytic  phosphatidylcholine,  etc.)  and  6  metabolic  pathways  (such  as  sphingomyelin
                                                             metabolism,  arginine  and  proline  metabolism,  sphingolipid
             Δ 基金项目 南京市高价值专利组合项目(No.K2020q05)                biosynthesis-lactose  and  neolactone  series).  Urine  metabonomics
             *第一作者 硕士。研究方向:中药分析及代谢组学。E-mail:
                                                             screened 20 different metabolites (such as prostaglandin A2, L-
          yu13693868679@163.com
                                                             valine,  phosphatidylcholine,  sphingomyelin,  etc.)  and  8
             # 通信作者 主任中药师,硕士生导师,博士。研究方向:中药健康
          产品研究与开发。E-mail:guzheng0512@163.com                 metabolic  pathways (such  as  valine,  leucine  and  isoleucine


          中国药房  2023年第34卷第17期                                              China Pharmacy  2023 Vol. 34  No. 17    · 2121 ·
   78   79   80   81   82   83   84   85   86   87   88